EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

G Protein-Coupled Receptor Kinase 2 Selectively Enhances β-Arrestin Recruitment to the D2 Dopamine Receptor through Mechanisms That Are Independent of Receptor Phosphorylation

Marta Sánchez-Soto iD, Noelia M Boldizsar iD, Kayla A Schardien, Nora S Madaras iD, Blair K A Willette, Laura R Inbody, Christopher Dasaro, Amy E Moritz, Julia Drube iD, Raphael S Haider, R Benjamin Free iD, Carsten Hoffman iD und 1 weitere

Biomolecules · 2023

DOI: 10.3390/biom13101552 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, 2023. Verfasst von Marta Sánchez-Soto und 12 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Neuropharmacology Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, 35 Convent Drive, Bethes…. Hauptthemen laut MEDLINE: G-Protein-Coupled Receptor Kinases, Receptors, Dopamine. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Intramural NIH HHS, National Institute of Neurological Disorders and Stroke Intramural Research Program, National Institutes of Health, European Regional Development Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The D2 dopamine receptor (D2R) signals through both G proteins and β-arrestins to regulate important physiological processes, such as movement, reward circuitry, emotion, and cognition. β-arrestins are believed to interact with G protein-coupled receptors (GPCRs) at the phosphorylated C-terminal tail or intracellular loops. GPCR kinases (GRKs) are the primary drivers of GPCR phosphorylation, and for many receptors, receptor phosphorylation is indispensable for β-arrestin recruitment. However, GRK-mediated receptor phosphorylation is not required for β-arrestin recruitment to the D2R, and the role of GRKs in D2R–β-arrestin interactions remains largely unexplored. In this study, we used GRK knockout cells engineered using CRISPR-Cas9 technology to determine the extent to which β-arrestin recruitment to the D2R is GRK-dependent. Genetic elimination of all GRK expression decreased, but did not eliminate, agonist-stimulated β-arrestin recruitment to the D2R or its subsequent internalization. However, these processes were rescued upon the re-introduction of various GRK isoforms in the cells with GRK2/3 also enhancing dopamine potency. Further, treatment with compound 101, a pharmacological inhibitor of GRK2/3 isoforms, decreased β-arrestin recruitment and receptor internalization, highlighting the importance of this GRK subfamily for D2R–β-arrestin interactions. These results were recapitulated using a phosphorylation-deficient D2R mutant, emphasizing that GRKs can enhance β-arrestin recruitment and activation independently of receptor phosphorylation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

G-Protein-Coupled Receptor KinasesReceptors, DopamineArrestinsbeta-ArrestinsPhosphorylationProtein IsoformsReceptors, G-Protein-CoupledHumansHEK293 CellsG-Protein-Coupled Receptor Kinase 2

Stichwörter der Autor:innen

D2 receptorGRKphosphorylationβ-arrestin

Substanzen

Arrestinsbeta-ArrestinsG-Protein-Coupled Receptor KinasesProtein IsoformsReceptors, DopamineReceptors, G-Protein-CoupledGRK2 protein, humanG-Protein-Coupled Receptor Kinase 2

Autor:innen und Institutionen

  • Molecular Neuropharmacology Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, 35 Convent Drive, Bethesda, MD 20892, USA.
  • Institut für Molekulare Zellbiologie, CMB-Center for Molecular Biomedicine, Universitätsklinikum Jena, Friedrich-Schiller-Universität Jena, Hans-Knöll-Straße 2, D-07745 Jena, Germany.
  • Division of Physiology, Pharmacology and Neuroscience, School of Life Sciences, Queen's Medical Centre, University of Nottingham, Nottingham NG7 2UH, UK.
  • Centre of Membrane Protein and Receptors, Universities of Birmingham and Nottingham, Birmingham B15 2TT, UK.

ORCID-Profile: Marta Sánchez-Soto, Noelia M Boldizsar, Nora S Madaras, Julia Drube, R Benjamin Free, Carsten Hoffman, David R Sibley

Förderung

  • Intramural NIH HHS
  • National Institute of Neurological Disorders and Stroke Intramural Research Program, National Institutes of Health
  • European Regional Development Fund
  • the federal state of Thuringia, and the Deutsche Forschungsgemeinschaft
  • University Hospital Jena IZKF

Zitieren

APA

Sánchez-Soto, M., Boldizsar, N. M., Schardien, K. A., Madaras, N. S., Willette, B. K. A., Inbody, L. R., Dasaro, C., Moritz, A. E., Drube, J., Haider, R. S., Free, R. B., Hoffman, C., & Sibley, D. R. (2023). G Protein-Coupled Receptor Kinase 2 Selectively Enhances β-Arrestin Recruitment to the D2 Dopamine Receptor through Mechanisms That Are Independent of Receptor Phosphorylation. Biomolecules. https://doi.org/10.3390/biom13101552

Vancouver

Sánchez-Soto M, Boldizsar NM, Schardien KA, Madaras NS, Willette BKA, Inbody LR, et al. G Protein-Coupled Receptor Kinase 2 Selectively Enhances β-Arrestin Recruitment to the D2 Dopamine Receptor through Mechanisms That Are Independent of Receptor Phosphorylation. Biomolecules. 2023. doi:10.3390/biom13101552

BibTeX
@article{SnchezSoto2023,
  author = {Sánchez-Soto, Marta and Boldizsar, Noelia M and Schardien, Kayla A and Madaras, Nora S and Willette, Blair K A and Inbody, Laura R and Dasaro, Christopher and Moritz, Amy E and Drube, Julia and Haider, Raphael S and Free, R Benjamin and Hoffman, Carsten and Sibley, David R},
  title = {G Protein-Coupled Receptor Kinase 2 Selectively Enhances β-Arrestin Recruitment to the D2 Dopamine Receptor through Mechanisms That Are Independent of Receptor Phosphorylation},
  journal = {Biomolecules},
  year = {2023},
  doi = {10.3390/biom13101552}
}
Kostenlos starten →